Vital Signs - Healthcare News - The Analysts Perspective August 2013 Issue

Regular Price: USD 450

Special Price USD 383

15% OFF

* Required Fields

Regular Price: USD 450

Special Price USD 383

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on August 31, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharma/Biotech, Advanced Medical Technology and Connected Health.

Table of Contents

Vital Signs - Healthcare News - The Analyst's Perspective August 2013 IssueVital Signs: August 31 2013This week's issue




Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.